Koyfin Home > Directory > Health Care > Antares Pharma > EV / Sales (ltm)

Antares Pharma EV / Sales (ltm) Chart (ATRS)

Antares Pharma annual/quarterly EV / Sales (ltm) from 2001 to 2018.
  • Antares Pharma EV / Sales (ltm) for the quarter ending March 03, 2018 was 6.20 a -48.54% decrease of -3.01 year over year
  • Antares Pharma Annual EV / Sales (ltm) for 2017 was 5.47 a -20.87% decrease of -1.14 from 2016
  • Antares Pharma Annual EV / Sales (ltm) for 2016 was 6.61 a 50.10% increase of 3.31 from 2015
  • Antares Pharma Annual EV / Sales (ltm) for 2015 was 3.30 a -285.16% decrease of -9.41 from 2014
Other Valuation Metrics:
  • Antares Pharma Market Cap for the quarter ending March 03, 2018 was $345m a -45.56% decrease of -157m year over year
  • Antares Pharma Price / Book for the quarter ending March 03, 2018 was 10.27 a -17.66% decrease of -1.81 year over year
  • Antares Pharma Enterprise Value for the quarter ending March 03, 2018 was $338m a -41.44% decrease of -140m year over year
View Chart On Koyfin

Quarterly ATRS EV / Sales (ltm) Data

03/20186.20
12/20175.47
09/20179.19
06/20179.22
03/20177.91
12/20166.61
09/20164.72
06/20162.43
03/20161.90
12/20153.30

Annual ATRS EV / Sales (ltm) Data

20175.47
20166.61
20153.30
201412.71
201323.42
201219.85
201114.09
201010.91
200910.36
20082.49